CheckMate 067: a phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with ipilimumab (IPI) versus IPI monotherapy in previously untreated patients (pts) with advanced melanoma (MEL)

被引：0

作者：

Wolchok, J. D. ^{[1
,2
]}

Chiarion-Sileni, V. ^{[3
]}

Gonzalez, R. ^{[4
]}

Rutkowski, P. ^{[5
,6
]}

Grob, J. ^{[7
]}

Cowey, C. L. ^{[8
]}

Lao, C. D. ^{[9
]}

Schadendorf, D. ^{[10
]}

Ferrucci, P. F. ^{[11
]}

Smylie, M. ^{[12
]}

Dummer, R. ^{[13
]}

Hill, A. ^{[14
]}

Haanen, J. ^{[15
]}

Maio, M. ^{[16
]}

McArthur, G. ^{[17
]}

Yang, A. ^{[18
]}

Rollin, L. ^{[19
]}

Horak, C. ^{[18
]}

Larkin, J. ^{[20
]}

Hodi, F. S. ^{[21
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] Weill Cornell Med Coll, New York, NY USA

[3] IRCCS, Oncol Inst Veneto, Padua, Italy

[4] Univ Colorado, Ctr Canc, Denver, CO 80262 USA

[5] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland

[6] Inst Oncol, Warsaw, Poland

[7] Hosp Timone, Marseille, France

[8] Texas Oncol Baylor Charles Sammons Canc Ctr, Dallas, TX USA

[9] Univ Michigan, Ann Arbor, MI 48109 USA

[10] Univ Essen Gesamthsch, Dept Dermatol, Essen, Germany

[11] European Inst Oncol, Milan, Italy

[12] Cross Canc Inst, Edmonton, AB, Canada

[13] Univ Spital Zurich, Zurich, Switzerland

[14] Tasman Oncol Res, Gold Coast, Qld, Australia

[15] Netherlands Canc Inst, Amsterdam, Netherlands

[16] Univ Hosp Siena, Siena, Italy

[17] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[18] Bristol Myers Squibb Co, Princeton, NJ USA

[19] Bristol Myers Squibb Co, Wallingford, CT 06492 USA

[20] Royal Marsden Hosp, London SW3 6JJ, England

[21] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

ANNALS OF ONCOLOGY | 2015年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B08

引用

页码：28 / 28

页数：1